List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 85 studies with search of: Open Studies | "Hypercholesterolemia"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Not yet recruiting A Study of Extended-release (ER) Niacin/Laropiprant in AdolescentsWith Heterozygous Familial Hypercholesterolemia (MK-0524A-158)
Conditions: Hypercholesterolemia, Familial;   Heterozygous Familial Hypercholesterolemia
Intervention: Drug: MK-0524A
2 Recruiting A Study to Determine the Safety, Tolerability, and Efficacy of AMG 145 in Subjects With Homozygous Familial Hypercholesterolemia.
Condition: Homozygous Familial Hypercholesterolemia
Interventions: Biological: AMG 145;   Other: Placebo
3 Not yet recruiting Efficacy and Safety of FDC in High Risk Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
Conditions: Hypercholesterolemia;   Dyslipidemia
Interventions: Drug: Rosuvastatin + Ezetimibe;   Drug: Simvastatin + Ezetimibe
4 Recruiting Effect of CER-001 on Plaque Volume in Homozygous Familial Hypercholesterolemia (HoFH) Subjects
Condition: Homozygous Familial Hypercholesterolemia
Intervention: Drug: CER-001
5 Unknown † Trial to Assess the Effects of P-OM3 on LDL-C in Subjects With Primary Hypercholesterolemia
Condition: Primary Hypercholesterolemia
Interventions: Drug: P-OM3;   Drug: Placebo
6 Unknown † Flaxseed Compared With Placebo in Patients With Hypercholesterolemia
Condition: Familial or Severe Hypercholesterolemia
Interventions: Dietary Supplement: flaxseed;   Dietary Supplement: whole wheat flour
7 Recruiting The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Condition: Homozygous Familial Hypercholesterolemia
Intervention:
8 Unknown † Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe
Condition: Heterozigous Familial Hypercholesterolemia
Intervention: Drug: Statins and Ezetimibe
9 Recruiting Cholesterol Lowering Treatment With Psyllium Husks and Isolated Soy Protein in Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Psyllium husks;   Dietary Supplement: Isolated soy protein;   Dietary Supplement: Isolated whey protein;   Other: Microcrystalline cellulose
10 Recruiting Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (Protocol MK-0524A-133 AM1)
Conditions: Primary Hypercholesterolemia;   Mixed Dyslipidemia
Interventions: Drug: Extended-release niacin/laropiprant (ERN/LRPT);   Drug: Placebo
11 Recruiting Long-Term Safety and Tolerability of SAR236553 (REGN727) in High Cardiovascular Risk Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: placebo;   Drug: SAR236553(REGN727)
12 Recruiting A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol
Conditions: Hypercholesterolemia;   Coronary Heart Disease
Interventions: Drug: mipomersen sodium 200 mg;   Drug: Placebo;   Drug: mipomersen sodium 70 mg
13 Recruiting Study to Assess the Tolerability and Efficacy of Anacetrapib Co-administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020 AM1)
Conditions: Hyperlipoproteinemia Type II;   Heterozygous Familial Hypercholesterolemia
Interventions: Drug: Anacetrapib;   Drug: Placebo for Anacetrapib
14 Recruiting MK0653C in High Cardiovascular Risk Patients With High Cholesterol (Switch Study)(MK-0653C-162 AM2)
Condition: Hypercholesterolemia
Interventions: Drug: ezetimibe (+) atorvastatin;   Drug: Comparator: ezetimibe (+) atorvastatin;   Drug: Comparator: atorvastatin, switching to ezetimibe (+) atorvastatin;   Drug: Comparator: atorvastatin;   Drug: Comparator: rosuvastatin, switching to ezetimibe (+) atorvastatin;   Drug: Comparator: rosuvastatin
15 Not yet recruiting Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils
Conditions: Hypertriglyceridaemia;   Familial Hypercholesterolaemia
Interventions: Dietary Supplement: Fish oil capsule;   Drug: HMG Coenzyme reductase
16 Recruiting Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Conditions: Diabetes Mellitus, Insulin-Dependent;   Hypercholesterolemia
Interventions: Drug: Atorvastatin;   Drug: Atorvastatin Placebo
17 Recruiting Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets
Conditions: Hypercholesterolemia;   HIV Infections
Interventions: Drug: Ezetimibe;   Drug: Rosuvastatin (standard care)
18 Recruiting Atorvastatin Three Year Pediatric Study
Condition: Familial Hypercholesterolemia
Intervention: Drug: atorvastatin
19 Not yet recruiting Effect of Mipomersen on LDL-Cholesterol Levels in Patients Treated by Regular Apheresis
Conditions: Atherosclerosis;   LDL-hypercholesterolemia
Intervention: Drug: mipomersen
20 Unknown † Soy Food Intervention Trial
Condition: Familial Hypercholesterolemia
Interventions: Dietary Supplement: soy protein diet;   Dietary Supplement: rapeseed oil

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services